Home / Systemic hormones / Octreotide
ATC H01CB02 · Pituitary and Hypothalamic Hormones and Analogues
Octreotide shortage
As of 31 Oct 2026, Octreotide has a reported shortage in 3 of the 5 countries we track (Italy, Spain, Austria), covering 6 products.
Countries3/5
Products6packs or presentations
Short since14 Jul 202516 months ago
Earliest return3 Nov 2026company estimate
No return date4products
Main reasonIncreased demand
Timeline
ItalySpainAustria
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | OCTREOTIDE SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 14 Jul 2025 | not given | Increased demand Elevata richiesta: distribuzione contingentata |
| IT | OCTREOTIDE SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 6 Jan 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| IT | OCTREOTIDE SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 15 Jan 2026 | not given | Increased demand Elevata richiesta/problemi produttivi |
| IT | OCTREOTIDE SUN | SUN PHARMACEUTICAL INDUSTRIES (EUROPE) B.V. | 4 Aug 2026 | not given | Manufacturing problem Problemi produttivi: distribuzione contingentata |
| ES | SANDOSTATIN 50 microgramos/ml SOLUCION INYECTABLE Y PARA PERFUSION , 5 ampollas de 1 ml | Novartis Farmaceutica S.A. | 20 Oct 2026 | 3 Nov 2026 | Not stated |
| AT | Sandostatin 50 Mikrogramm/ml Injektions-/Infusionslösung, 5 Stück limited | Novartis Pharma GmbH | 8 Oct 2026 | 23 Nov 2026 | Distribution or logistics Verzögerung bei der Auslieferung |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.